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Policy Points:
 From 2011 to 2013, immunization proponents won significant leg-
islative victories that tightened philosophical exemptions in Wash-
ington, Oregon, and California.
 Highlighting data on the high rates of unvaccinated children and
subsequent, preventable infectious disease outbreaks has proven to
be quite compelling to state lawmakers, especially when combined
with physician expert testimony. Even vigorous protest from vaccine-
critical organizations failed to defeat recent legislative wins when
other political conditions were favorable.
 Our research suggests that immunization proponents have not been
as active as they could be, and that much of the energy in pressing
for new policies over the past 15 years has been on the vaccine-critical
side of the aisle.
Context: This article examines trends in state-level childhood vaccine poli-
cies in the United States from 1998 to 2012 and explains the trajectories for
both vaccine-critical and proimmunization legislative efforts. Successful mo-
bilization by vaccine critics during the height of the autism and thimerosal
scares (roughly 1998 to 2003) yielded a few state-level expansions for the most
permissive type of exemption from vaccine mandates for public school atten-
dance, those based on personal beliefs. Vaccine-critical positions, however, have
largely become discredited. How has vaccine critics’ ability to advance preferred
policies and prevent the passage of unfavorable legislation changed over time?
Methods: We created a unique data set of childhood vaccine bills (n = 636),
introduced from 1998 to 2012 across the 50 state legislatures, and coded them
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by type of effort (exemption, mandate, mercury ban, and information policies)
and outcome. We then mapped out the trends in vaccine policies over time.
In order to contextualize the trends we identified, we also reviewed numerous
primary sources and conducted interviews with stakeholders.
Findings: In general, we found that vaccine critics’ legislative success has begun
to wane. In only 20 bills in our data set were vaccine critics able to change
policy in their preferred direction via the legislative process. Only 5 of thosewins
were significant (such as obtaining a new philosophical exemption to vaccine
mandates), and the last of these was in 2007. Critics were more successful at
preventing passage of proimmunization legislation, such as mandates for the
human papillomavirus (HPV) vaccine.
Conclusions: Recent legislation in California, Oregon, and Washington that
tightened philosophical exemptions by means of informational requirements
suggests that vaccine politics may be entering another phase, one in which
immunization supporters may be able to counter increasing opt-out rates,
particularly in states with recent outbreaks and politicians favoring science-
based policies.
Keywords: child, health legislation, United States, vaccination.
D uring the last 15 years, there has been greatcontroversy in the United States over childhood vaccine pol-icy. This controversy was initially sparked by a paper—later
retracted by The Lancet1—and press conference comments by British
gastroenterologist Andrew Wakefield in which he speculated that the
measles component of the MMR (measles-mumps-rubella) vaccine was
associated with autism. Also, in the United States, the revelation that a
mercury-based preservative, thimerosal, was present in vaccines at levels
that could exceed 1 of 3 different regulatory standards prompted its
removal from the US vaccine supply.2 In fact, vaccines have always been
controversial,3 and much of our vaccine safety and injury compensation
system owes its existence to concerns in the 1980s about adverse reac-
tions to the diphtheria-pertussis-tetanus, or DTP, vaccine, and many of
the activists who mobilized against the vaccine remain organized today.
Nonetheless, despite the linkages to past vaccine controversies, we
argue that the fears regarding the MMR vaccine that emerged from the
Wakefield paper and the thimerosal revelations in the late 1990s mark
the start of a unique period in the history of US vaccine politics. This
period is characterized by very low levels of vaccine-preventable diseases,
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an increase in the number of vaccines recommended for children, high
levels of organized interest-group activity opposing vaccine mandates,
diffusion of doubt about vaccine safety among some parents, greater use
of exemptions to avoid or delay childhood vaccinations, and large in-
vestments in research and promotion of scientific results demonstrating
the safety of the US vaccine supply.
The 1998 Wakefield paper and the 1999 thimerosal revelation and
removal helped vaccine critics portray vaccines as unsafe. But have re-
cent events—such as the discrediting of the link between autism and
vaccines and the publicity of outbreaks of whooping cough, Hib disease,
and measles—reversed or slowed the gains made by vaccine critics at the
state level? Indeed, political activists at organizations like the National
Vaccine Information Center (NVIC) recently reported more challeng-
ing conditions for their efforts in state houses.4 We hypothesized that
perhaps the conditions that enabled vaccine critics to enact favorable
legislation have changed since the early days of the autism-vaccine and
thimerosal scares of the late 1990s and early 2000s. Our first objective,
therefore, was to systematically map out all state-level bills introduced
by both vaccine critics and immunization supporters spanning the pe-
riod of initial controversy, the human papillomavirus (HPV) mandate
push in the mid-2000s, the 2010 Wakefield retraction, and the disease
outbreaks currently worrying state officials. We examined what we term
immunization boundary policies, which determine which vaccines chil-
dren are mandated to receive, who can be exempted from these vaccines,
and whether the use of some vaccines is restricted because of mercury
content. Boundaries can be drawn around vaccines—which are included
in a state’s mandate and which are not, for example—or around people
subject to the vaccine mandate. Boundary policies can vary according
to how many vaccines are mandated or how easy it is to evade them by
opting out of vaccination. We also examined what we term information
policies, which seek to inform parents of vaccine ingredients present in
their child’s immunizations and thus may lead them to question the vac-
cines’ safety, as well as those policies that aim to educate parents about
vaccine-preventable diseases. Our second objective was to find patterns
in the timing and content of legislative efforts surrounding childhood
vaccinations.
There is a great deal of public health research on vaccines, lay risk as-
sessments of their relative safety, and the effects of various immunization
policies, such as state exemptions or new proposals to mandate the HPV
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vaccine.5-9 One recently published study analyzed state vaccine politics
from 2011 to 2013, noting that while more bills had been introduced
to broaden vaccine exemptions, only those tightening the exemption
policies actually passed.10 No study has yet charted the outcomes of
state-level political controversies across this entire tumultuous period
and shown systematically the trajectories of the multifaceted legislative
efforts of vaccine critics and immunization proponents. This article ex-
amines US state-level legislative attempts to change vaccine policy from
1998 to 2012, categorizes the legislative efforts made, and explains the
outcomes of these efforts. In order to better understand these outcomes,
we also offer observations about the factors driving political fortunes in
vaccine debates based on primary sources from a selection of these polit-
ical struggles, and we close with predictions for the future of state-level
vaccine politics.
State Policies Governing Policy
Boundaries and Information Provision
Struggles Over the Boundaries of Vaccine Policies
State legislatures are a critical location for policy contestation over vac-
cines, as vaccine mandates are matters of state law (although federal
approval by the US Food and Drug Administration [FDA] and recom-
mendation by the Advisory Committee on Immunization Practices of
the Centers for Disease Control and Prevention [CDC] must precede
any state mandate). Legislatures can directly set vaccine policy, grant
discretion to the state public health department to do so, or both. The
first pivotal struggle over vaccine law and policy that we describe per-
tains to the boundaries of a state’s childhood vaccine mandate, which
requires a set of immunizations before admission to public schools (and,
in some states, to day care). How can one evade these boundaries? Many
states grant exemptions from mandated vaccines for medical, religious,
or philosophical reasons. Some states also exempt children with demon-
strated immunity to a disease, usually proved by a blood test or a disease
history. Exemptions based on philosophical or personal beliefs permit
parents to “opt out” of immunizations without claiming a religious rea-
son or a medical contraindication. Most parents seeking an exemption
because of vaccine safety concerns find the philosophical exemption to be
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the best-fitting justification. Christian Scientists may claim a religious
exemption to vaccination, but none of the major religious groups in the
United States have a doctrinal ban on vaccination.
We found no consensus in previously published works and on interest
groups’ websites about precisely which states offer which kinds of ex-
emptions. Some state statutes do not clearly define what kinds of beliefs
are the basis for an exemption, and because each state’s legal regime is
shared among the legislature, health administrators, and courts, it may
not be obvious from the statutes alone how the exemptions actually
function in practice. For example, a state may not explicitly list a reli-
gious exemption, even though religious belief can be considered a subset
of its “personal belief” exemption. California is a state with a statutory
personal belief exemption but no explicit religious exemption. In 2012,
however, because Governor Jerry Brown noted in a signing statement to
a recent bill that administrators would honor religious exemptions, we
count California as having a religious exemption in practice.
Adding to the complexity, a state can have a religious exemption
but no philosophical exemption. Administrators or judges, however,
can order that there be no interrogation of the basis of the religious
exemptions, so they function as de facto philosophical exemptions. The
questions in these disputes are whether a state must accommodate reli-
gion by permitting a religious exemption under the free exercise clause
of the First Amendment, how stringently the state may define what
qualifies as religious belief or membership, and whether the differen-
tial treatment of religious people, as opposed to anyone else seeking
an exemption, is permissible. Lawsuits by parents have tested religious
exemptions in many jurisdictions, generating different court opinions
on whether the state can require a certain level of demonstrated sincerity
of religious belief or membership in a recognized religious order. New
York courts and federal courts applying New York law have permitted
inquiry into sincerity and religious membership, holding that scientific
doubts about vaccines,11 chiropractic ethical objections,12 and fears that
vaccines cause autism13 do not count as valid reasons for invoking the
religious exemption. Nonetheless, litigation in New York also estab-
lished that membership in a religious organization is not required.14 In
Arkansas, litigation struck down that state’s requirement that petition-
ers for exemptions belong to a recognized religious group with a doc-
trinal opposition to vaccination,15 and the next year the legislature en-
acted a broader philosophical exemption. In New Jersey, administrative
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directives prohibit examining the content of religious belief or member-
ship, and in Florida16 andWyoming,17 judicial opinions have forbidden
any administrative inquiry into the details of the religious belief. We
regard these states as having a de facto philosophical exemption.
We analyzed the specific wording of each state’s statutes and reviewed
state administrative practices and court decisions to summarize what
exemptions are offered, as of 2012, both “on the books” and in prac-
tice. In a majority of states, the legal statutes and practice are clear and
unambiguous. Mississippi and West Virginia clearly offer only medi-
cal exemptions. Furthermore, 25 states clearly offer only religious and
medical exemptions (Alabama, Alaska, Connecticut, Delaware, Geor-
gia, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, Maryland, Mas-
sachusetts, Montana, Nebraska, Nevada, NewHampshire, NewMexico,
NewYork,North Carolina, Rhode Island, South Carolina, SouthDakota,
Tennessee, and Virginia). We consider the religious exemptions in these
states clear because they explicitly refer to religious membership, prac-
tice, or tenets, rather than using language indicating the inclusion of
secular beliefs such as “ethical values.” In addition, these states have
no court opinions directing administrators to accept, without scrutiny,
a petitioner’s claims about religious belief. Thirteen states specify the
existence of both religious and philosophical exemptions (Arkansas, Col-
orado, Idaho, Maine, Michigan, North Dakota, Ohio, Oklahoma, Texas,
Utah, Vermont, Washington, and Wisconsin).
In contrast, we found the exemption policies of 10 states to be un-
clear. The statutes of 6 states (Arizona, California, Louisiana, Minnesota,
Oregon, and Pennsylvania) are ambiguously worded in such a way as
to group together all nonmedical exemptions using broad language,
thereby making it difficult to determine whether they offer both a reli-
gious and a philosophical exemption or just a philosophical one. These
states typically refer to their nonmedical exemption as being based on a
“personal belief,” ethical convictions, values, or similarly inclusive lan-
guage.We counted these states as having both religious and philosophical
exemptions because both rationales are supported by the language and
there are no court cases to the contrary. Although Governor Brown’s
explicit directive made California’s religious exemption clear, we placed
it with the unclear cases because many parents may not be aware of
it. Florida remains somewhat ambiguous even after the court decision
rendering its religious exemption a de facto philosophical exemption,
because it was heard in the First District in Tallahassee but was not
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reviewed and affirmed in Florida’s supreme court. The Wyoming case,
by contrast, was a state supreme court ruling that applied statewide, but
we counted it as unclear because Wyoming citizens may not know that
religious claims have no restriction on their meaning if they are unaware
of the ruling. Likewise in New Jersey, administrative directives have
created a de facto philosophical exemption (interview with Drew Harris,
New Jersey Public Health Institute, July 2013), but a citizen looking
up the statute would not know that. Finally, Missouri regulations allow
philosophical exemptions for preschool and day care, but not for K-12
education. We consider Missouri to offer only a religious exemption,
since our focus is on school requirements nationwide. In total, we found
that as of 2012, 50 states hadmedical exemptions, 48 states had religious
exemptions, and 22 states had philosophical exemptions.
Legislative struggles over boundaries appeared following public con-
cerns about the safety of the MMR vaccine and thimerosal, as vaccine-
critical groups worked hard to expand state-level exemptions to manda-
tory childhood vaccination policies or to remove mandates entirely.
Changes in exemption policy are noteworthy because with broad ex-
emption policies in place, parents can easily forgo mandated vaccines.
At what we have identified as the high point of vaccine-critical or-
ganizing, 3 states added new philosophical exemptions (Arizona in
2002 by regulation, and thus not a part of our database, and Texas
and Arkansas in 2003 through legislative efforts). When exemptions
are easy to obtain, their usage increases and is higher than in states that
have either no philosophical exemption or some informational or admin-
istrative requirements making exemptions somewhat more difficult to
secure.18
Struggles Over the Provision of Vaccine
Information
The second pivotal struggle during this recent period was over the in-
formation that must be presented about vaccines, vaccine-preventable
disease, and their consequences. This information is often relayed in the
conversation between a health care provider and the parents during an
immunization visit, but perhaps also in more broadly distributed mate-
rials. Vaccine-critical activists have made much of the fact that vaccines
contain formaldehyde or mercury, or may have been developed with
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cell lines originally obtained from aborted human fetuses (eg, rubella,
varicella, and hepatitis A).19 Introducing bills requiring that parents be
informed about vaccine ingredients is part of a strategy to heighten per-
ceptions that vaccines are dangerous. Highlighting vaccine ingredients
also rhetorically links the vaccine-critical cause with health movements
against environmental contaminants and with natural food movements.
The complexity of vaccine ingredients may sit awkwardly with cultural
norms against eating food products that contain processed ingredients
with, for instance, long and complex-sounding names. As the popular
food author Michael Pollan warned, “If you can’t pronounce it, don’t
eat it.”20 These vaccine-critical bills also may be presented as simply
more information for the consumer, a popular value in health care com-
munication. The ingredient bills then put immunization supporters in
the difficult position of arguing against the presentation of information
that will be hard for them to discuss fully in a brief office visit. Doctors,
too, may object to the accuracy of the information presented by vaccine
critics about ingredients because it actually may be incorrect or because
information furnished by a physician may legitimate critics’ claims that
certain ingredients are unsafe. Immunization advocates have also put
forth informational bills, particularly where there is no state mandate
for a particular vaccine, such as for HPV or influenza. These informa-
tional bills require that parents be told that the vaccine is available and
be advised of the risks of the disease it prevents, which may encourage
parents to voluntarily vaccinate their child.
Conceptual Framework
To analyze the trajectories of state childhood vaccine policy, we used
Thomas Oliver’s conceptual framework for examining the politicization
of health controversies.21 Oliver cites 3 factors as important to determin-
ing whether a health issue comes to be seen as properly political, that is,
requiring a public solution negotiated through power relations among
people. First, there must be a risk assessment that captures sufficient at-
tention to mobilize the public and their representatives; second, there
must be an appropriately targeted locus of responsibility that is widely
regarded as the cause of the problem; and third, there must be an ap-
pealing social construction of target populations who need help from a policy
change.21(pp197–203)
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We argue that these 3 factors (risk assessment, locus of responsibility,
and social construction of target populations) help explain the overall
trends we present here. Vaccine critics enjoyed some traction with these
factors in the early years of the autism-vaccine scare, securing favorable
policy changes by arguing that vaccines were risky, that the govern-
ment was responsible for lax oversight of profiteering pharmaceutical
companies, and that vulnerable children and their well-informed par-
ents deserved to make their own vaccine choices. But then the tide
turned against the autism-vaccine hypothesis, and the political lever-
age of these arguments weakened as well. We show that immunization
advocates recently contended, successfully, that resurgences of diseases
like whooping cough are the real risks, that higher opt-out rates and lax
exemption laws are to blame, and that vulnerable newborns need more
protection in the form of stiffer exemption policies.
Methods
We created an original database of state legislative policy efforts re-
garding vaccine requirements from 1998 to 2012 (n = 636) and coded
these efforts by intent (meaning simply their purpose or the action they
were introduced to create, such as mandating a newly approved vaccine)
and by outcome (enactment into law, or failure by being held in com-
mittee or voted down). We built the database by searching LexisNexis
State Capital, the National Conference of State Legislatures, the Access
World News database, Association of State and Territorial Health Offi-
cials, and advocacy group websites and newsletters, such as the NVIC
and the American Academy of Pediatrics. We used the “bill tracking by
keyword” function in LexisNexis State Capital using the search terms
“vacc!” or “immuniz!” and not “cattle” or “dog” or “veterinar!” between
the years 1998 and 2012. We also used the search terms “vaccine” or
“vaccination”; “child” or “children”; “mandate,” “exemption,” or “opt-
out”; and “bill,” “measure,” or “legislation” between January 1, 2009,
and May 30, 2012, in Access World News. If the bill’s purpose was
unclear from the title or description, we reviewed the full text when it
was available. (The complete database is available from Denise Lillvis by
request.) One of us reviewed and coded the bills, consulting the other 2
when the bill’s intent was unclear. In addition, a fourth researcher con-
ducted a blinded replication of the database in which she repeated our
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search process for 20% (150) of the 750 state-years included in our study
and was able to independently reproduce more than 90% of the database.
No other study has so comprehensively examined child vaccine policy
across a relatively long period of time and across all 50 states. Although
this method of legislative database research is standard in the public
health and political science literature, we also included a replication
exercise that further validates the comprehensiveness of our sampling.
Boushey and Pacheco22 constructed a database of state vaccine legisla-
tion from 1990 to 2010, and as we did, they collected data regarding
bill introductions using a LexisNexis State Capital keyword search. Un-
like our study, though, which targeted a specific population (children),
Boushey and Pacheco focused on 11 vaccine policy areas, such as em-
ployment, school-related mandates, and animals. A study by Colgrove,
Abiola, and Mello6 examined data on the legislation state, date of intro-
duction, date of last action, and outcome of HPV mandates from 2006
to 2008. Other studies have been able to utilize state legislation datasets
collected by government entities. For example, Shipan and Volden23
looked at 3 types of smoking policies from 1975 to 2000: government
building restrictions, restaurant restrictions, and out-of-package sales
restrictions. For their analysis, they used data collected by the National
Cancer Institute, including whether the law passed, when it passed, and
its content.
Because we focused on childhood vaccine policy, we did not include
bills on topics such as the influenza vaccine for health care workers or
bills specifically about emergency preparedness. But in order to capture
as broad a sense of the politics as possible, we included bills that were
aimed at wider issues but that encompassed child vaccine policy, such
as mercury bans and ingredient information bills. We counted each bill
introduced in a state during the calendar year as 1 legislative effort, and
if we identified the bill as part of a House/Senate bill pair, we counted the
pair as 1 effort. Legislative efforts were defined as introduced bills that
were grouped into the following 9 categories based on their legislative
intent. If a bill had more than 1 legislative intent (eg, a mandate and
a provision of disease risk information), we counted each intent within
the bill as a distinct effort.
We classified each bill into 1 of the following 9 categories:
1. Exemption expansion: an effort to make it easier to opt out of vac-
cines by creating a new exemption or broadening an existing one.
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This includes exemptions from vaccinations via demonstrations
of immunity.
2. Exemption contraction: an effort to make it more difficult to opt out
of vaccines by either withdrawing or adding more requirements
to an existing exemption.
3. Mandate expansion: an addition of a recommended vaccine to a
state’s list of mandated childhood vaccines, or the expansion of
the public health department’s powers to monitor or add to a
state’s mandate policy (excluding influenza mandates).
4. Mandate contraction: a deletion of a mandated vaccine from a
state’s list of mandated childhood vaccines, or the restriction or
burdening of the public health department’s powers to monitor
or add to a state’s mandate policy.
5. Mercury ban expansion: a bill banning mercury or thimerosal from
vaccines in that state or for use in a particular population sub-
group, or a bill expanding a preexistingmercury ban to a broader
population of people (such as children under age 8 instead of
children under 3).
6. Mercury ban contraction: an amendment to an existing mercury
ban allowing the use of mercury in some circumstances or pop-
ulations or for a particular vaccine (such as influenza), often sub-
stantially undercutting or functionally overruling the original
ban.
7. Mercury information: a bill requiring health care providers to tell
parents about mercury in vaccines, with the expectation that
this information will promote more refusals of vaccines or will
frame vaccines as dangerous in the conversation with a health
care provider.
8. Ingredient information: a bill requiring health care providers to
give parents a list of vaccine ingredients with the expectation
that this information will increase the refusals of vaccines or
frame vaccines as dangerous in the conversation with a health
care provider.
9. Disease risk information (in the absence of, or as a complement to,
a mandate): a bill requiring health care providers to tell patients
about the risks of a disease for which there is a vaccine available
but that might not be mandated in that state (such as HPV),
with the expectation that this information will promote use of
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the vaccine by framing it as necessary to avoid contracting the
disease.
The first 6 categories are boundary struggle categories, which contest
what the state’s childhood vaccinemandate will include, how stringent it
will be, and whether the use of mercury-containing vaccines is restricted.
The last 3 categories are informational struggle categories, which con-
test the public information, patient-provider interaction, and what is
considered accurate information about vaccines’ risks and benefits. We
coded outcomes of the legislative efforts from the vaccine critics’ perspective,
according to the following definitions:
1. Offensive win: Enactment of a law sponsored or supported by
vaccine critics (ie, exemption expansion, mandate removal, mer-
cury ban initiation or ban expansion, mercury information, or
ingredient information).
2. Offensive loss: Failure of a bill sponsored or supported by vaccine
critics.
3. Defensive win: Failure of a bill opposed by vaccine critics (ie,
an exemption contraction, mandate enactment, mercury ban
contraction, or disease risk information).
4. Defensive loss: Enactment of a law opposed by vaccine critics.
Of course, not every bill in our database would be recognizable to a
partisan in the vaccine debates as a genuine controversy. Some bills were
introduced with only 1 sponsor and quietly died in committee. Others,
particularly the efforts by the proimmunization side to add a newly
approved vaccine, are routine efforts that were certainly not devised as a
political proimmunization strategy. Many bills seem controversial only
from a vaccine-critical political perspective, and while these are actively
monitored nationwide by the NVIC’s Advocacy Portal (its grassroots
mobilization website for political organizing), the bills are unknown
outside these networks. We attempted to balance our comprehensive
approach of including every bill, regardless of its prominence, with
highlights of important wins and losses and pivotal points of shifting
political opportunity.
To better understand the trajectory of vaccine-critical legislative ef-
forts, we studied the policymakers’ own reasons as well as the arguments
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made directly to them by lobbyists and constituents. We conducted
16 phone interviews with legislators (11) or their staffers (5) across
several states (California, Kansas, Maine, New Hampshire, Vermont,
and Washington). Because many legislators did not respond to our in-
terview requests or could not remember details about past debates, we
conducted the interviews based on availability and whether there was
legislative activity in the recent past (2009-2012). We also interviewed
3 members of the public health community (ie, those in or close to state
immunization program bureaucracies in New Jersey and Vermont, as
well as a representative from a national immunization organization). In
addition, we surveyed 266 state and local newspaper articles across 30
states, as well as bill analyses, testimonies, a signing statement, and other
relevant documents across 12 states to capture policymakers’ “primary
voices.” When it was available, we examined primary-source evidence
from advocates, lobbyists, and individuals in the form of written and
oral testimony given directly to legislators. We used this information
to verify the purpose and outcomes of the bills, presented in this article
in the Results section, and we used the themes in the primary data to
contextualize our findings, in the Discussion section.
Our study has some limitations. First, our review of news sources (used
to obtain quotations from legislators and to find any bills we may have
missed) centered on the 2009 to 2012 time period, so our results heremay
have undercounted omnibus bills containing changes in vaccine policy
that may have been mentioned in the news but that we did not find
when searching for bills. But because we consulted numerous sources,
we believe that any such omissions are few. Second, our causal claims
about a bill’s success or failure are tentative and supported by qualitative
data that were very difficult to obtain, came from different types of
sources, and were spread unevenly across states. We tried to interview
many more legislators and ask them directly what they thought led to
the fates of the bills they worked on, but most did not respond to our
requests and some could not remember many details at all. Some had
been persuaded by vaccine-critical groups to refuse to talk to us because
of their mistrust of our research perspective, which made it difficult
to interview a variety of stakeholders. Given these difficulties, we did
not highlight our interview data in the Results section; rather, we used
the data to clarify and contextualize trends in the bills’ introduction,
passage, or failure.
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Results
Our study of recent state-level legislative efforts surrounding childhood
vaccine policies revealed a range of politicization and legislative activity
and captured noteworthy themes and trends. See Figures 1 and 2 for
a representation of the trends in introduced bills in all US states by
category from 1998 to 2012. Figure 1 illustrates the bills’ boundary
struggle categories, with the trends in attempts to alter which vaccines
aremandated and tomake exemptions easier or harder to obtain. Figure 2
shows the trends in the informational struggle categories, with the
attempts to promote vaccines and the efforts to portray them as toxic
and dangerous.
Because our results are from the vaccine-critical perspective, the ef-
forts advancing their cause appear on the positive side of the axis showing
the number of legislative efforts. Both legislative efforts to expand the
availability of exemptions and efforts to contract the number of man-
dated vaccinations were made throughout the period (with the exception
of 2006). The first legislation to ban mercury in vaccinations appeared
in 2001, and the first legislation to inform parents about the dangers of
mercury as an ingredient in vaccines appeared in 2003. Bills regarding
information about ingredients appeared sporadically, starting in 2002.
Legislative efforts advancing the proimmunization perspective appear
on the negative side of the horizontal axis. Most of these pertained to
expanding the number of mandated vaccines and were followed soon
after by bills requiring disease risk information to be provided to parents.
Unlike the ingredient information bills, these bills framed vaccination in
a positive light and highlighted the dangers of communicable diseases.
Such efforts peaked in 2007, coinciding with a major legislative push to
inform the public of HPV and to mandate a HPV vaccine for school-age
children. Legislative efforts to lessen mercury bans also began to appear
in 2007. Finally, intermittently throughout the study period, we found
efforts to limit parents’ ability to obtain vaccine exemptions; these efforts
peaked in 2012.
Figure 3 displays the numbers of bills by state from 1998 to 2012,
according to outcome category from the vaccine-critical perspective (ie,
offensive win, defensive win, offensive loss, defensive loss). Table 1 lists
the 20 “offensive wins” that were the clearest victories for vaccine critics
during the study period, and Table 2 breaks down the outcomes by the
different types of boundary and informational efforts.
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The central question driving our study was whether there has been a
noticeable decline in political opportunities for vaccine critics.We argue
that there certainly has. Vaccine critics hoped to achieve offensive wins
in exemption expansions, mandate removals, mercury ban enactments
and expansions, and mercury ingredient and vaccine ingredient bills.
Despite the vaccine-critical movement’s success at placing favorable
policies on the legislative agenda and blocking some bills they oppose,
critics have not succeeded in transforming childhood vaccine policy in
their preferred direction over time. As Table 2 shows, vaccine critics
and their legislative allies have not achieved any offensive wins in the
form of exemption expansions since 2003.We counted only 20 offensive
wins across the nation during the study period. Table 1 presents the
specific state, bill, and a brief description of these laws. The last of the
4 mandate contraction wins occurred in 2007 (out of 32 nationwide
attempts to roll back mandates during the study period). The critics’
most recent offensive wins, in the form of mercury ban expansions (8
of which were passed nationwide during our study period), were in
2008; mercury bans or ban expansions failed to pass another 98 times,
however (Tables 1 and 2). Of the 20 offensive wins for vaccine critics,
some are quite unimportant (such as Oklahoma’s 1998 removal of the
smallpox vaccine mandate when routine smallpox vaccination already
had ended in the United States in 1972), largely redundant (the 8
bills regarding mercury-free vaccines, when mercury already had been
ordered removed from nearly all vaccines several years before), or useful
only for the most determined parent trying to avoid vaccination (several
bills allowing waivers for children who can prove prior immunity to the
disease through exposure or a blood test).
But what kinds of successes have vaccine critics nonetheless been able
to sustain? Vaccine-critical boundary victories were limited to “defen-
sive wins,” or legislative efforts in which vaccine critics were able to
fend off bids to make it more difficult to avoid childhood vaccines, such
as those in Arizona and Vermont in 2012. Notably, between 2002 and
2010, a time when exemption rates were rising in many communities
across the United States, no states were able to contract exemptions in
any way, although immunization supporters introduced 9 bills to do
so. Furthermore, during our study period the vaccine-critical movement
was able to thwart 19 attempts at constraining exemptions and 127
attempts at adding vaccines to the mandated requirements (although
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37 of the latter defensive wins involved HPV, which has been a con-
troversial mandate for many reasons, and it is likely that a rejected
mandate for vaccines other than HPV will be mandated in a later year
by the legislature or the health department). Even though the initial
attempts were unsuccessful, bills mandating specific childhood vaccina-
tions eventually passed in California, Iowa, Indiana, New Jersey, Ohio,
and Virginia. In Washington, the legislation failed and was never rein-
troduced; instead, the mandate was instituted by the health department
(a 2005 varicella mandate). Political science research on the dynamics of
political mobilization in democratic legislatures predicts that this kind
of defensive success will be easier to obtain than a full-scale policy shift
in another direction, which often is difficult without a large, bipartisan
coalition.24
While these defensive wins are definitive successes from the vaccine-
critical perspective, over the last couple of years, the movement began
to lose ground in staving off exemption contractions. During the time
period of this study, both Washington and California made it more
difficult for parents to receive an exemption by adding a conversation
with a health care provider as a precondition for obtaining the exemption.
In 2013, Oregon followed suit. As we discuss in more detail later, these
defeats occurred even though vaccine critics were highly mobilized to
fight them. These recent moves to restrict parents’ abilities to obtain
exemptions after years of maintaining the status quo suggest that the
political landscape may be getting tougher for vaccine critics, especially
in states with high exemption rates and lax policies. Restricting access to
philosophical exemptions may prove to be just as effective as eliminating
the exemption altogether.
Vaccine critics also have attempted to influence public perceptions
of vaccines by mandating that doctors show parents a list of vaccine
ingredients or inform them when a vaccine contains mercury. During
our study period, none of the ingredient awareness bills became law.
It remains to be seen whether vaccine-critical groups will continue to
use this strategy to persuade parents to reconsider vaccine risks. Even
though critics have not succeeded in transforming official vaccine com-
munication through the information bills, they have blocked numerous
attempts at providing disease risk information that is meant to per-
suade parents to have their child vaccinated (58 defensive wins and 37
defensive losses in this information category).
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Despite a highly salient debate over vaccines conducted since the
late 1990s, we found that vaccine politics varies widely in the degree
of controversy and change from state to state. Five states had almost
no legislative efforts related to the vaccine policies of interest during
the study period, meaning either there was no legislative activity in
any of our 9 categories from 1998 to 2012 or perhaps only one bill
that died in committee in one year. For example, Alaska’s only recorded
legislative effort during the study period, a failed exemption expansion,
came in 2000. At the opposite end of the spectrum, New York State
recorded 66 controversies resulting in 11 changes to the legislative
status quo. The 2 most restrictive states, West Virginia and Mississippi,
offer only medical exemptions to childhood vaccination mandates and
have sustained many unsuccessful challenges to maintaining that policy
over the last 15 years, 32 and 39 efforts, respectively. None led to policy
change inWest Virginia. Mississippi enacted 3 vaccine policy changes—
a mandate expansion and 2 laws to provide disease risk information—
but did not expand the exemptions. Table 3 shows the state variation
in policy change from the perspective of the vaccine-critical movement.
Here, an offensive win indicates that a proposed bill favorable to vaccine
critics passed in this state during the study period, and a defensive loss
means that a proposed bill unfavorable to vaccine critics passed.
Discussion
Our descriptive data cannot supply a causal account for what is driving
legislative change, but we can begin to fill in the story of why these pol-
icy changes occurred by offering details from a broader look at primary
sources and interview data. Given the important role that exemption
policies play, we highlight 2 distinct inflection points in our data, corre-
sponding to the years 2003 and 2011.We argue that 2003 is meaningful
because it was the last time that vaccine critics won theirmost significant
policy victory—new routes to opting out, with the philosophical exemp-
tions in Texas and Arkansas—and that 2011 is important because it is
the year in which vaccine critics began to sustain significant defensive
losses in the form of narrowed philosophical exemptions. These 2 points
are characterized by shifts in Oliver’s framework in regard to risk assess-
ment, locus of responsibility, and construction of target populations.We
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Table 3.Wins and Losses by State That Resulted in Policy Change
Change Favorable Change Unfavorable
Proposed Offensive win (15 states) Offensive loss
favorable AR, CA, DE, FL, IA, IL,
KY, MO, ND, NH,
NJ, NY, OK, TX, VA
TNa
Proposed Defensive win Defensive loss (34 states)
unfavor-
able
VTb CA, CO, DE, GA, HI, IA,
IL, IN, KS, KY, LA, MA,
MD, ME, MI, MN, MO,
MS, NC, ND, NE, NJ,
NM, NY, OH, OK, OR,
RI, SC, SD, TN, TX,
VA, WA
aTennessee is recorded as an offensive loss because a bill initially proposed in 2011 excluded
home-schooled children from a vaccine mandate, but the resulting bill passed with an
amendment striking this part of the bill.
bVermont is recorded as a defensive win because legislation proposed in 2012 would have
removed the philosophical exemption to vaccination; however, the law as passed resulted
in the exemption being retained.
have simplified the politics, posited 2 sides to the debate (which we have
termed vaccine critics and immunization supporters), and described the fluc-
tuating political fortunes of the 2 sides using this framework. If critics
are able to convince legislators that vaccines pose a safety risk, at least to
some children; that overly aggressive public health policies, profiteering
pharmaceutical companies, and a vaccine-happy federal government are
responsible for creating this risk; and that well-informed parents and
vulnerable children need legislative protection from coercion, they are
likely to succeed, as was demonstrated between 1998 and 2003. But if
immunization supporters can turn the conversation to the risks of un-
vaccinated children spreading disease in communities with permissive
exemption policies; to parents’ misinformation as the locus of responsi-
bility; and to children vulnerable to diseases, such as those too young
or too ill to be vaccinated, as those needing protection, then vaccine
critics will have greater difficulty achieving success—a trend that began
in 2011. Next we describe several of the most important recent events
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in vaccine politics and how these rhetorical controversies played a role
in the legislative outcomes.
Exemption Expansions at a High Point of
Vaccine Criticism, 1998-2003
As we noted earlier, the last year in which there were any significant
offensive wins for vaccine critics was 2003, in which both Texas and
Arkansas enacted new philosophical exemptions. It is likely that 2003
was a high watermark of vaccine suspicion because parents had been
mobilized for several years, but much of the research that discredited
the link between vaccines and autism had not yet been published, and
the public embarrassments of Dr. Andrew Wakefield were still several
years away.25 In contrast to the vaccine critics, the proimmunization
groups were slower to organize and respond to the autism-vaccine con-
troversy. The account by Texas activist Dawn Richardson of the fight
for the 2003 exemption showcases a politically savvy side of vaccine-
critical politics, in which instilling credibility, trust, and moderation;
cultivating relationships over time in the legislature; avoiding parti-
san divides; and creating an appealing personal image paid off after 7
years of efforts.26 Richardson advised advocates to emphasize the risks
of vaccines by pulling out the manufacturer’s own package insert and
reading off the list of possible adverse effects, which are required to
appear in the insert, regardless of whether a causal relationship has been
established. In the legislative hearing records we obtained, vaccine crit-
ics consistently shared personal stories of vaccine damage, emphasizing
the risks in highly emotional terms. They blamed the pharmaceutical
companies and the government for insufficient attention to safety and
presented themselves as a sympathetic target group in need of legislation
to protect their parental rights. Together, these themes were persuasive
in a conservative legislature in 2003. In our interviews touching on
more recent struggles, however, legislators told us that while parents
are still very mobilized, the debunking of Wakefield’s research is now
widely known, and thus the perceptions of vaccine-adverse events are
not the political advantage they once were. While vaccine critics have
tried to distance themselves fromDr.Wakefield and frame their concerns
more broadly, we found that Wakefield’s name operated as a heuristic to
indicate credibility problems with vaccine criticism generally.
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The American Controversy: The Mercury Bills,
2001-2012
Mercury revelations certainly galvanized US-based vaccine critics at the
turn of the century. Activists capitalized on some unfavorable publicity
about thimerosal in vaccines and amplified uncertainty about its pos-
sible effects. Thimerosal, which is about half ethyl mercury by weight,
had been added to vaccines since the 1930s to prevent harmful bac-
teria from growing in multiuse vials.27 The hepatitis B vaccine, the
DTaP (diphtheria, tetanus, and acellular pertussis) vaccine, and the Hib
(Haemophilus influenzae type b) vaccine all contained thimerosal, which
could have delivered up to 187.5 μg (micrograms) of ethyl mercury to
an infant in the first 6 months of life (ie, if she or he received an as-
sortment of vaccines with the highest possible levels, although many
combinations would have delivered less ethyl mercury). According to
the FDA,28 thimerosal remains in some multidose vials of flu vaccine
(25μg and 12.5μg for a version administered to children under 3). The
MMR vaccine has never contained thimerosal. After complying with a
1997 law requiring the FDA to survey mercury additives in products,
federal regulators realized in 1999 that a child could potentially be ex-
posed to more ethyl mercury (as thimerosal) through the recommended
vaccine schedule than the Environmental Protection Agency (EPA) limit
for methyl mercury, which is a different type of mercury that is a known
environmental contaminant in fish. Methyl mercury was well studied
at the time, but ethyl mercury was not, and it did not have its own
safety standard. Accordingly, as a precaution, the American Academy of
Pediatrics (AAP) and the US Public Health Service (USPHS) quickly
recommended the removal of thimerosal from vaccines.2
A 2001 report on thimerosal-containing vaccines (TCVs) held that it
was “biologically plausible” that thimerosal could be related to autism
and that the evidence was inadequate to accept or reject a causal relation-
ship owing to insufficient research.29 Activist parents quickly organized
around the amount of mercury in the 1990s childhood vaccine sched-
ule and published a paper arguing that autism could be a new form of
mercury poisoning.30 By 2002, there were 68 lawsuits pending in 16
states alleging damage from mercury in vaccines or requesting health
monitoring after receipt of a mercury-containing vaccine, 11 of which
were putative (uncertified) class actions potentially covering more than
175 million people.31 (These lawsuits did not progress because they had
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to move into the vaccine injury compensation court and could not be
brought as regular civil actions.)
Although the paper by Bernard and colleagues, alleging that autism
is similar to mercury poisoning, was soon debunked,32 those parents
had mobilized to form SafeMinds, a prominent vaccine-critical activist
group. By 2004, enough new studies had been published that an Institute
of Medicine (IOM) review committee rejected hypotheses connecting
either the MMR vaccine or thimerosal in vaccines to autism.33 A few
years later, special masters at the federal vaccine injury compensation
court ruled that the MMR vaccine and thimerosal in vaccines had not
been shown to have caused autism as a vaccine injury.34
Overall, mercury politics in the United States has moved from the
initial uncertainty and activist mobilization at the turn of the 21st
century to mainstream scientific acceptance by the CDC, the IOM,
the AAP, the World Health Organization, and the United Nations
Environment Programme (UNEP) that thimerosal in vaccines is not
harmful. Furthermore, its usefulness in keeping vaccines free of harmful
pathogens endures, in both themanufacturing process and global vaccine
programs in which the use of single vials is not always practicable.
The vaccine-critical, antimercury movement persists, however, though
some of its focus has shifted from vaccines to mercury pollution more
generally.25
Our study of the arc of mercury bills in the states confirms the
overall story of initial scandal and mobilization followed by mainstream
acceptance that these fears were unfounded. As we noted, 8 mercury bans
were enacted, but 98 were not. The mercury bills that vaccine critics
were able to pass would have had little impact beyond some multidose
vials of the flu vaccine, since thimerosal already had been removed from
other vaccines. Many states subsequently modified their mercury bans so
broadly (such as passing a bill saying that a medical provider could use
any vaccine approved by the FDA) that they were completely eviscerated.
Activists have been unsuccessful both nationally and internationally in
advancing their antithimerosal goals. The Mercury-Free Vaccines Act
has been introduced 4 times in Congress (2004, 2005, 2007, and 2009)
in the last decade by both Republicans and Democrats, but none of these
bills ever made it out of committee.35 In January 2013, the UN finalized
language on the Minamata Convention on Mercury, which exempts
mercury use in vaccines from its global efforts to reduce exposure to
mercury.36 Our data show that in recent years, general vaccine ingredient
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bills have replacedmercury bills as the bill of choice to introduce, though
without success. Although ideas about alarming vaccine ingredients do
have traction in the media and as a focus of parental concerns, these bills
have not proved to be promising policy avenues for vaccine critics.
The West Coast Exemption Contractions of
2011-2013
Health policy scholars have observed that tightening philosophical ex-
emption requirements by adding informational steps before opting out
(usually obtaining a physician’s signature stating that he or she dis-
cussed vaccine risks and benefits with the family) would likely slow the
increasing rates of exemptions.37-39 Proimmunization state legislators
clearly heeded the suggestion, and between 2011 and 2013, the 3 West
Coast states of California, Oregon, and Washington increased the strin-
gency of their philosophical exemptions by requiring parents to obtain
information from a health care provider about the benefits and risks of
vaccination in order for their child to qualify for an exemption. Our
primary-source research into the background of the policy changes in
California and Washington revealed 6 reasons for the bills’ final suc-
cess: (1) the high salience of recent pertussis outbreaks in the states;
(2) a sense among immunization supporters that their state was being
shamefully singled out for having a nationally high opt-out rate; (3) a
persistent, scientifically credible, and well-led coalition in support of the
bills; (4) a reduction in the opposition’s credibility, specifically around
the debunking of the autism-vaccine hypothesis and the retraction of
Dr. Wakefield’s work, which made it difficult for them to draw in new
supporters in the legislature; (5) the separation of the Christian Scien-
tist community and its concerns from the concerns of parents opposed
to vaccines for nonreligious reasons; and (6) the successful framing of
the bills as increasing information rather than persecuting parents or
restricting choices.
Washington had the country’s highest rate of unvaccinated schoolchil-
dren in 2011, according to a CDC report,40 and then whenWashington’s
exemption rate dropped after its new law went into effect, the unflatter-
ing spotlight came to rest on Oregon, with the nation’s highest rate of
unvaccinated kindergarteners in 2012.41 The CDC report was the first
time that it ranked the states based on their vaccination rates. As Oliver’s
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analysis predicts, risk assessment can become highly salient when there
are hard numbers to point to, and the enumeration and publication of
which states had the highest opt-out rates clearly were very important to
creating the necessary sense of urgency for policy change in the Pacific
Northwest.
These bills passed despite vigorous opposition from the NVIC and
other allied groups. The core coalition of vaccine opposition is composed
primarily of libertarian health freedom activists, alternative medicine
practitioners and adherents, chiropractors and homeopaths, and mobi-
lized parents who believe that vaccines are unsafe (and who often lean
libertarian or reject mainstream medicine themselves).25 The NVIC is-
sued action alerts to its members encouraging them to contact legislators
in opposition, and they were successful at disseminating their message.
In addition, a lobbyist represented the NVIC at the Washington state
capitol to speak against the measure. Other groups also testified against
the bill inWashington: the ChristianHomeschool Network, Talk About
Curing Autism, and the locally organized Mercury Awareness Team, as
well as some individual parents and children. The media noted the level
of activism from citizen opponents in Washington, describing them as
packing hearings, lobbying lawmakers, and turning out 100 people or
more at committee hearings.42 Washington and California legislators
and their staff who guided these bills through to passage noted that
while there still were vocal vaccine-critical celebrities such as comedian
Rob Schneider and mobilized families staunchly opposed, they were not
able to bring in new allies and had lost the support of some legislators
who changed theirminds in light of the debunking of the autism-vaccine
hypothesis or were not reelected. Although this energetic mobilization
is likely to continue in many states, as a new state rises to the top of the
CDC’s list of the highest exemption rates, we would expect to see more
bills proposing additional restrictions on exemption policies.
Conclusion
The vaccine-critical movement has been able to establish a network of
advocates poised to seek out and support new legislative opportunities
while defending their cause against unfavorable legislation. Vaccine
critics are mobilized, well funded, and not going away.25 As the lead
NVIC political organizer noted in her recent newsletter to activists,
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mobilizing for legislative battles, even when they are lost, is important
to recruiting and training new volunteers for the organization.4 Even
strategies that were not very successful, such as the vaccine ingredient
bills, help keep the vaccine-critical agenda in front of the legislature
and mobilize supporters. Critics will no doubt remain vigilant for the
next crisis in vaccine trust that will shift Oliver’s concepts of risk,
responsibility, and target population back to more favorable terms. In
the meantime, vaccine supporters face the challenge that when vaccines
work well, it is easy not to notice the good they do and thus harder to
muster passionate political support.
Immunization proponents have clearly found a new way to win with
theWest Coast strategy of tightening (but not attempting to remove) lax
exemption policies. Those state policy changes were supported by federal
research and publicity—particularly the CDC’s ranking of states with
the largest numbers of exempted children—and immunization propo-
nents certainly could continue to maximize the significant informational
advantages that come from, for example, sharing immunization goals
with federal agencies and research hospitals. One of the proimmuniza-
tion force’s greatest advantages is the expertise and credibility of every
mainstream medical and governmental organization.
Evenwith this advantage, there are other ways that immunization pro-
ponents can make the most of recent political opportunities. Our inter-
views and primary-source documents make clear that vaccine critics have
been quite successful at directing attention to children allegedly hurt by
vaccines. Immunization supporters thus could do more to highlight the
sympathetic figures on their side, such as immune-compromised chil-
dren who rely on herd immunity, or unvaccinated people who contracted
vaccine-preventable diseases and regret not being vaccinated. We found
that disease risk information bills were the only policy innovation dur-
ing our study period from the proimmunization side; in other words,
immunization supporters could certainly take the initiative to introduce
a variety of proactive bills based on current events, much like the vaccine
critics’ attempts to pass mercury ban and ingredient bills. For example,
a bill could require that schools and day care centers publicly post or
distribute to parents the percentage of students with vaccine exemp-
tions or the percentage of staff who have received a flu shot or whooping
cough booster, as news coverage of disease outbreaks has raised public
awareness about the unvaccinated. Although these numbers already have
been collected, their public release would generate the news coverage
Power and Persuasion in the Vaccine Debates 505
and scrutiny that have proved helpful in the West Coast’s legislative
changes. States with high rates of philosophical exemptions and lax pro-
cedures also may be suitable targets for new requirements specifying that
parents (or students) talk with a physician before obtaining an exemp-
tion. Indeed, the Colorado legislature considered House Bill 14-1288,
which included making school exemption data publicly available and
requiring discussions with a health care professional (or the completion
of an online education module) before obtaining an exemption. The
bill that eventually passed did not include the health care professional
discussion or education requirement. We believe that even as immu-
nization supporters lament high exemption rates and worry about the
recurrence of vaccine-preventable diseases, the political trajectories of
vaccine controversies in the states portend a positive trend back in their
favor.
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